Ultrasound-Guided RSCTL vs EOIP Block for Analgesia in Sleeve Gastrectomy

NCT07311525 | Recruiting

• 1 other identifier: FMBSUREC/05102025/Fakhry
• Study Type: interventional
• Target: 90
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study is to compare the effect of ultrasound-guided retro-SCTL space block and EOI block on opioid consumption within 24 hours after LSG.

Conditions

Patient Satisfaction

Keywords

Sleeve Gastrectomy; Postoperative Analgesia; External Oblique Intercostal Plane Block; Retro superior costotransverse ligament space block

Outcome Measures

Primary Outcomes (1)

• cumulative morphine consumption within the first 24 hours.

  cumulative morphine consumption within the first 24 hours.

  24 hours post operative

Secondary Outcomes (2)

• Visual analogue scale (VAS) score for pain

  30 minutes, 1, 3, 6, 12, 24 hours postoperatively

• A Sedation scale

  Initial 24 hours postoperatively

Study Arms (2)

retro-SCTL block

ACTIVE COMPARATOR

Participants in the (group retro-SCTL) will receive ultrasound-guided retro-SCTL space block after intubation. Following hydrodissection with 2 ml of 0.9% saline to confirm the correct needle tip position, 20 ml 0.25% bupivacaine was injected. The same procedure was then repeated with 20 ml 0.25% bupivacaine on the contralateral side.

Procedure: ultrasound-guided Retro superior costotransverse ligament space block

EOI block

ACTIVE COMPARATOR

Participants in the (group EOI) will receive ultrasound-guided EOI block after intubation. Following hydrodissection with 2 ml of 0.9% saline to confirm the correct needle tip position, 20 ml 0.25% bupivacaine was injected. The same procedure was then repeated with 20 ml 0.25% bupivacaine on the contralateral side.

Procedure: ultrasound-guided External Oblique Intercostal Plane Block

Interventions

ultrasound-guided External Oblique Intercostal Plane Block PROCEDURE

Participants will receive ultrasound-guided External Oblique Intercostal Plane Block after intubation.Following hydrodissection with 2 ml of 0.9% saline to confirm the correct needle tip position, 20 ml 0.25% bupivacaine was injected. The same procedure was then repeated with 20 ml 0.25% bupivacaine on the contralateral side.

EOI block

ultrasound-guided Retro superior costotransverse ligament space block PROCEDURE

Participants will receive ultrasound-guided Retro superior costotransverse ligament space block after intubation. Following hydrodissection with 2 ml of 0.9% saline to confirm the correct needle tip position, 20 ml 0.25% bupivacaine was injected. The same procedure was then repeated with 20 ml 0.25% bupivacaine on the contralateral side.

retro-SCTL block

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients aged between 18 to 65 years
• Both genders
• American Society of Anesthesiologists (ASA) physical status I-II
• Body mass index (BMI) \> 40 kg m-2,

You may not qualify if:

• Obesity secondary to an endocrine disorder
• known allergic diathesis to any drugs used in the study
• Presence of serious systemic illness (e.g., severe cardiac, pulmonary, renal, or hepatic dysfunction),
• Coagulation dysfunction
• Pre-existing psychological disorders
• Current use of analgesic or psychotropic medications
• Infection at a potential injection site
• Ahistory of chronic pain
• Conversion to laparotomy.

Sponsors & Collaborators

• Beni-Suef University: lead

Study Sites (1)

Beni-Suef University hospital

Banī Suwayf, Beni Suweif Governorate, 62511, Egypt

RECRUITING

MeSH Terms

Conditions

Patient Satisfaction

Condition Hierarchy (Ancestors)

Treatment Adherence and Compliance; Health Behavior; Behavior

Study Officials

• Dina M Fakhry, MD

  Beni-Suef University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Dina M Fakhry, MD

CONTACT

00201289998680; dina_fakhry_91@yahoo.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: QUADRUPLE
• Who Masked: PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Lecturer of Anesthesiology, Surgical Intensive Care and Pain Management

Study Record Dates

• First Submitted: December 10, 2025
• First Posted: December 31, 2025
• Study Start: February 1, 2026
• Primary Completion (Estimated): February 1, 2027
• Study Completion (Estimated): February 1, 2027
• Last Updated: January 6, 2026

Record last verified: 2026-01

Locations

EG (1)